Drug screening platform using human induced pluripotent stem cell‐derived atrial cardiomyocytes and optical mapping

Current drug development efforts for the treatment of atrial fibrillation are hampered by the fact that many preclinical models have been unsuccessful in reproducing human cardiac physiology and its response to medications. In this study, we demonstrated an approach using human induced pluripotent s...

Descripción completa

Detalles Bibliográficos
Autores principales: Gunawan, Marvin G., Sangha, Sarabjit S., Shafaattalab, Sanam, Lin, Eric, Heims‐Waldron, Danielle A., Bezzerides, Vassilios J., Laksman, Zachary, Tibbits, Glen F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2020
Materias:
Cell‐based Drug Development, Screening, and Toxicology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7780813/
https://www.ncbi.nlm.nih.gov/pubmed/32927497
http://dx.doi.org/10.1002/sctm.19-0440

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7780813/
https://www.ncbi.nlm.nih.gov/pubmed/32927497
http://dx.doi.org/10.1002/sctm.19-0440

Ejemplares similares